Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

International Stem Cell (ISCO) Shares Outstanding (Diluted Average) (2016 - 2025)

Historic Shares Outstanding (Diluted Average) for International Stem Cell (ISCO) over the last 14 years, with Q3 2025 value amounting to $8.2 million.

  • International Stem Cell's Shares Outstanding (Diluted Average) rose 203.52% to $8.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.2 million, marking a year-over-year increase of 203.52%. This contributed to the annual value of $8.0 million for FY2024, which is 0.0% changed from last year.
  • As of Q3 2025, International Stem Cell's Shares Outstanding (Diluted Average) stood at $8.2 million, which was up 203.52% from $8.0 million recorded in Q2 2025.
  • In the past 5 years, International Stem Cell's Shares Outstanding (Diluted Average) ranged from a high of $8.2 million in Q3 2025 and a low of $7.8 million during Q2 2021
  • Its 5-year average for Shares Outstanding (Diluted Average) is $8.0 million, with a median of $8.0 million in 2022.
  • Examining YoY changes over the last 5 years, International Stem Cell's Shares Outstanding (Diluted Average) showed a top increase of 305.14% in 2022 and a maximum decrease of 0.0% in 2022.
  • International Stem Cell's Shares Outstanding (Diluted Average) (Quarter) stood at $7.8 million in 2021, then increased by 2.19% to $8.0 million in 2022, then changed by 0.0% to $8.0 million in 2023, then changed by 0.0% to $8.0 million in 2024, then increased by 2.04% to $8.2 million in 2025.
  • Its Shares Outstanding (Diluted Average) stands at $8.2 million for Q3 2025, versus $8.0 million for Q2 2025 and $8.0 million for Q1 2025.